Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

(215)

Capital expenditures 157 93

Dividends 138 380

Proceeds from sale of Transfusion Therapies

business - (421)

Proceeds from stock issued under employee

benefit plans (112) (201)

Purchases of treasury stock 545 270

Acquisitions of and investments in businesses

and technologies 61 31

Payments relating to settlements of

cross-currency swaps 169 147

Other, including the effect of exchange

rate changes (10) (64)

-------------------------------------------------------------------------

Increase in net debt 586 20

-------------------------------------------------------------------------

Net debt, March 31 $1,136 $336

=========================================================================

Key statistics, March 31:

Days sales outstanding 56.3 55.3

Inventory turns 2.3 2.6

BAXTER INTERNATIONAL INC.

Net Sales

Periods Ending March 31, 2008 and 2007

(unaudited)

($ in millions)

-------------------------------------------------------------------------

%Growth %Growth

@ @


'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... China Sky One,Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs ... that the Company has 30 medicines that will ... Basic Medical Insurance, Industrial Injury Insurance,and Maternity Insurance ... 30 medicines treat a variety of common ailments ...
(Date:12/15/2009)... (AFM) have been developed and are opening up a new ... The NeedleProbes’ cylindrical geometry enables researchers to measure surface tension, ... in a single force distance curve. , ... ... NeedleProbes are enabling unique measurements at the liquid/air ...
(Date:12/15/2009)... On January 20th, 2010, the inaugural European meeting ... (ISMPP) will be held at the Royal College ... attendees are expected at this prestigious event, providing ... medical writers and medical agencies to discuss the ... of guidelines and regulations such as GPP-2, FDAAA ...
(Date:12/14/2009)... Calif., Dec. 14 Array BioPharma Inc. ... AMGN ) today announced that they entered into ... Array,s small-molecule glucokinase activator program, including ARRY-403, currently ... in patients with Type 2 diabetes. ... will receive an upfront payment of $60 million ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... $8.1 Million Financing in ... Reverse Stock Split Planned for January ... ) today announced that the Company has:, - Signed an ... company based in Israel. The acquisition,is expected to close tomorrow. The ...
... Dec. 4 Immtech Pharmaceuticals,Inc. (AMEX: IMM ... an exclusive,license to BioAlliance Pharma SA (Euronext Paris ... pafuramidine maleate (pafuramidine), in,Europe for the treatment of ... treatment of Human African trypanosomiasis, also known as,African ...
... Healthcare,Technologies Ltd. (NASDAQ: HCTL ), announced today ... shareholders (approximately 90%),voted in favor of the NexGen ... were asked to approve the previously,announced Asset Purchase ... Gamida for Life B.V. and the transactions contemplated,thereby, ...
Other Biology Technology:Amarin Signs Agreement to Acquire Ester Neurosciences 2Amarin Signs Agreement to Acquire Ester Neurosciences 3Amarin Signs Agreement to Acquire Ester Neurosciences 4Amarin Signs Agreement to Acquire Ester Neurosciences 5Amarin Signs Agreement to Acquire Ester Neurosciences 6Amarin Signs Agreement to Acquire Ester Neurosciences 7Amarin Signs Agreement to Acquire Ester Neurosciences 8Amarin Signs Agreement to Acquire Ester Neurosciences 9Amarin Signs Agreement to Acquire Ester Neurosciences 10Amarin Signs Agreement to Acquire Ester Neurosciences 11Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 3Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 4Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction 2
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/13/2009)... The Scripps Research Institute have solved a 10-year-old ... ancient family of enzymes can have two completely ... providing guidance for understanding other molecules in the ... the protein,s possible use for combating diseases including ... published in the December 13, 2009 advance, online ...
(Date:12/11/2009)... school children understand that green plants photosynthesize, absorb ... the profound global-scale effects that photosynthesis has had ... on the origins and evolution of photosynthesis is ... School of Life Sciences. , Oxygen, one of ... cyanobacteria and their descendants (including algae and higher ...
Breaking Biology News(10 mins):Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3Your Online Resource For Plastic Surgery Information 62930 1Your Online Resource For Plastic Surgery Information 62930 2Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 1Statement of HDMA President and CEO John M Gray on the Importation of Prescription Drugs 62928 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 1BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 3
... the Dana-Farber Cancer Institute (Dana-Farber), Burnham Institute for ... Control and Prevention (CDC) have reported the identification ... unprecedented range of influenza A viruses, including avian ... and some seasonal influenza viruses. These antibodies have ...
... Mass., Feb. 17 LocatePLUS Holdings Corporation ... provider of investigative, identity validation, and homeland ... 2009 election of an entirely independent Board ... Board through the consent of a majority ...
... came in,first place in the global SIMagine competition, ... the world,s largest event for mobile communication.,The awarded ... and,enables fast-lane service using fingerprint recognition and mobile ... a global competition focusing on new innovative solutions ...
Other Biology News:Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses 3LocatePLUS Announces Election of Independent Board 2LocatePLUS Announces Election of Independent Board 3LocatePLUS Announces Election of Independent Board 4Mobile Communication Market Opens up for Biometrics - Precise Biometrics Awarded 1st Prize at GSMA World Mobile Congress 2
... Immunogen: Synthetic peptide derived from the N-terminal ... ZO-1. Specificity: Specific for the N-terminus ... Reactivity: Human Dog Rat Mouse (positive controls: ... mouse liver heart blood vessel and brain ...
p-Raf-1 (Ser 338/Tyr 341)-R...
Human/Mouse APLP-1 MAb (Clone 354020) ENTREZ GeneID: 333...
... Lauryl Ether 30% concentration ... Preservative. Surfactant. Clear Solution. ... is 1 mL of ... added to 400 mL ...
Biology Products: